《肝衰竭诊治指南(2024年版)》更新热点解读  

Interpretation of key updates in the Guideline for diagnosis and treatment of liver failure(2024 version)

作　　者：李君[1] 罗金晋 Li Jun;Luo Jinjin(State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,National Medical Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China)

机构地区：[1]浙江大学医学院附属第一医院传染病重症诊治全国重点实验室、国家感染性疾病临床医学研究中心、国家传染病医学中心感染性疾病诊治协同创新中心,杭州310003

出　　处：《中华临床感染病杂志》2024年第5期367-370,388,共5页Chinese Journal of Clinical Infectious Diseases

摘　　要：肝衰竭是临床常见的严重肝病症候群,病死率极高。我国近期发布了《肝衰竭诊治指南(2024年版)》。新版指南在2018年版的基础上,全面汇总了国内外最新研究成果,旨在进一步规范和指导临床实践。本文对新版指南中慢加急性肝衰竭(ACLF)的定义与诊断标准、ACLF的预警和预后评估及肝衰竭的治疗等主要更新内容进行解读。Liver failure is a common clinical syndrome of severe liver disease with rapid progression and high mortality.The Guideline for diagnosis and treatment of liver failure(2024 version)was released recently,which was developed on base of the 2018 edition and the latest research progress,offering standardized protocols and evidence-based recommendations for the management of liver failure.This article interprets the key upgrates of the guideline,including the definition and diagnostic criteria,early warning and prognosis assessment of acute-on-chronic liver failure(ACLF),and the treatment of liver failure.

关 键 词：慢加急性肝衰竭 指南 解读 诊断标准 

分 类 号：R57[医药卫生—消化系统]